These findings indicate that IL-8 increases plasma levels and is associated with an increase in RANKL neutrophils in COPD patients, while also suggesting the systemic inflammatory environment may be a mechanism driving RANKL expression by neutrophils in COPD. Here, CXCL8 is linked to chronic obstructive pulmonary disease.